Management of cerebral vasculopathy in children with sickle cell anaemia (Q33904379)

29 July 2017

1 reference

title

Management of cerebral vasculopathy in children with sickle cell anaemia (English)

1 reference

29 July 2017

0 references

Powars DR

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

British Journal of Haematology

29 July 2017

published in

1 reference

29 July 2017

volume

108

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

666-678

1 reference

Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

The use of transcranial ultrasonography to predict stroke in sickle cell disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Alpha thalassemia and stroke risk in sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Cerebrovascular accidents (strokes) in children with sickle cell disease residing at high and low altitudes of Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Stroke in a cohort of patients with homozygous sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Preservation of sickle cell blood-flow patterns during MR imaging: an in vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Effect of age at the start of iron chelation therapy on gonadal function in beta-thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Recurrent cerebral ischemia during hypertransfusion therapy in sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Neuropsychologic effects of stroke in children with sickle cell anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Cognitive screening examinations for silent cerebral infarcts in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Transplanted sickle-cell disease patients with autologous bone marrow recovery after graft failure develop increased levels of fetal haemoglobin which corrects disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Ischemic stroke and incomplete infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

MRA of the intracranial circulation in asymptomatic patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Accuracy of neurologic examination and history in detecting evidence of MRI-diagnosed cerebral infarctions in children with sickle cell hemoglobinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Sickle cell disease in a Brazilian population from Sao Paulo: a study of the beta s haplotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Perspectives series: cell adhesion in vascular biology. Adhesive interactions of sickle erythrocytes with endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Measurement of regional cerebral blood flow, blood volume and oxygen metabolism in patients with sickle cell disease using positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

21 January 2018

Neuroprotective therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Symptomatic carotid artery occlusion. A reappraisal of hemodynamic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Abnormal cranial magnetic resonance imaging scans in sickle-cell disease. Neurological correlates and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Prothrombotic changes in children with sickle cell disease: relationships to cerebrovascular disease and transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Prediction of adverse outcomes in children with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Proton magnetic resonance spectroscopy: an emerging technology in pediatric neurology research

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Cerebral blood flow mapping using stable xenon-enhanced CT in sickle cell cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Hydroxyurea in children with sickle cell disease: impact on splenic function and compliance with therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Natural history of sickle cell anemia in Saudi Arabs. A study of 270 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Brain glucose metabolism in neurologically normal patients with sickle cell disease. Regional alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Transcranial Doppler, MRA, and MRI as a screening examination for cerebrovascular disease in patients with sickle cell anemia: an 8-year study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Quantitative MRI of the brain in children with sickle cell disease reveals abnormalities unseen by conventional MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Diffuse T1 reduction in gray matter of sickle cell disease patients: evidence of selective vulnerability to damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Selective expression of adhesion molecules on human brain microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Moyamoya disease: the disorder and surgical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of eryt

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Encephaloduroarterio-synangiosis in a child with sickle cell anemia and moyamoya disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Abnormalities of the central nervous system in very young children with sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Investigation of stroke in sickle cell disease by 1H nuclear magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Evidence of misery perfusion and risk for recurrent stroke in major cerebral arterial occlusive diseases from PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

Cognitive deficits associated with frontal-lobe infarction in children with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01912.X

10.1046/J.1365-2141.2000.01912.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference